These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12871854)

  • 41. Assessment of the antiviral properties of recombinant porcine SP-D against various influenza A viruses in vitro.
    Hillaire ML; van Eijk M; van Trierum SE; van Riel D; Saelens X; Romijn RA; Hemrika W; Fouchier RA; Kuiken T; Osterhaus AD; Haagsman HP; Rimmelzwaan GF
    PLoS One; 2011; 6(9):e25005. PubMed ID: 21935489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A unique sugar-binding site mediates the distinct anti-influenza activity of pig surfactant protein D.
    van Eijk M; Rynkiewicz MJ; White MR; Hartshorn KL; Zou X; Schulten K; Luo D; Crouch EC; Cafarella TR; Head JF; Haagsman HP; Seaton BA
    J Biol Chem; 2012 Aug; 287(32):26666-77. PubMed ID: 22685299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity.
    Hartshorn KL; White MR; Voelker DR; Coburn J; Zaner K; Crouch EC
    Biochem J; 2000 Oct; 351 Pt 2(Pt 2):449-58. PubMed ID: 11023831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multimerization of surfactant protein D, but not its collagen domain, is required for antiviral and opsonic activities related to influenza virus.
    White M; Kingma P; Tecle T; Kacak N; Linders B; Heuser J; Crouch E; Hartshorn K
    J Immunol; 2008 Dec; 181(11):7936-43. PubMed ID: 19017984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surfactant protein A alters endosomal trafficking of influenza A virus in macrophages.
    Yau E; Yang L; Chen Y; Umstead TM; Atkins H; Katz ZE; Yewdell JW; Gandhi CK; Halstead ES; Chroneos ZC
    Front Immunol; 2023; 14():919800. PubMed ID: 36960051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of influenza viral neuraminidase activity by collectins.
    Tecle T; White MR; Crouch EC; Hartshorn KL
    Arch Virol; 2007; 152(9):1731-42. PubMed ID: 17514488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.
    Hsu SF; Su WC; Jeng KS; Lai MM
    J Virol; 2015 Apr; 89(7):3671-82. PubMed ID: 25589657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms.
    Giles SS; Zaas AK; Reidy MF; Perfect JR; Wright JR
    PLoS One; 2007 Dec; 2(12):e1370. PubMed ID: 18159253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effects of diketopiperazines from Moslae Herba against influenza A virus-induced pulmonary inflammation via inhibition of viral replication and platelets aggregation.
    Zhang HH; Yu WY; Li L; Wu F; Chen Q; Yang Y; Yu CH
    J Ethnopharmacol; 2018 Apr; 215():156-166. PubMed ID: 29309861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Type I interferon-mediated immune response against influenza A virus is attenuated in the absence of p53.
    Zhu Z; Yang Y; Wei J; Shao D; Shi Z; Li B; Liu K; Qiu Y; Zheng H; Ma Z
    Biochem Biophys Res Commun; 2014 Nov; 454(1):189-95. PubMed ID: 25450379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D.
    Holmskov U; Mollenhauer J; Madsen J; Vitved L; Gronlund J; Tornoe I; Kliem A; Reid KB; Poustka A; Skjodt K
    Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10794-9. PubMed ID: 10485905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers.
    Honda Y; Takahashi H; Kuroki Y; Akino T; Abe S
    Chest; 1996 Apr; 109(4):1006-9. PubMed ID: 8635323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HDAC6 Restricts Influenza A Virus by Deacetylation of the RNA Polymerase PA Subunit.
    Chen H; Qian Y; Chen X; Ruan Z; Ye Y; Chen H; Babiuk LA; Jung YS; Dai J
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses.
    Tecle T; White MR; Gantz D; Crouch EC; Hartshorn KL
    J Immunol; 2007 Jun; 178(12):8046-52. PubMed ID: 17548642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conglutinin acts as an opsonin for influenza A viruses.
    Hartshorn KL; Sastry K; Brown D; White MR; Okarma TB; Lee YM; Tauber AI
    J Immunol; 1993 Dec; 151(11):6265-73. PubMed ID: 8245465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage.
    Kuan SF; Rust K; Crouch E
    J Clin Invest; 1992 Jul; 90(1):97-106. PubMed ID: 1634623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Critical role for cross-linking of trimeric lectin domains of surfactant protein D in antiviral activity against influenza A virus.
    Tecle T; White MR; Sorensen G; Gantz D; Kacak N; Holmskov U; Smith K; Crouch EC; Hartshorn KL
    Biochem J; 2008 Jun; 412(2):323-9. PubMed ID: 18302538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinctive anti-influenza properties of recombinant collectin 43.
    Hartshorn KL; Holmskov U; Hansen S; Zhang P; Meschi J; Mogues T; White MR; Crouch EC
    Biochem J; 2002 Aug; 366(Pt 1):87-96. PubMed ID: 11971759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutralizing inhibitors in the airways of naïve ferrets do not play a major role in modulating the virulence of H3 subtype influenza A viruses.
    Job ER; Pizzolla A; Nebl T; Short KR; Deng YM; Carolan L; Laurie KL; Brooks AG; Reading PC
    Virology; 2016 Jul; 494():143-57. PubMed ID: 27110707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variant size- and glycoforms of the scavenger receptor cysteine-rich protein gp-340 with differential bacterial aggregation.
    Eriksson C; Frängsmyr L; Danielsson Niemi L; Loimaranta V; Holmskov U; Bergman T; Leffler H; Jenkinson HF; Strömberg N
    Glycoconj J; 2007 Apr; 24(2-3):131-42. PubMed ID: 17243023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.